Precigen Stock (NASDAQ: PGEN) stock price, news, charts, stock research, profile.
Open | $1.50 |
Close | $1.58 |
Volume / Avg. | 1.84M / 808.03K |
Day Range | 1.47 - 1.62 |
52 Wk Range | 0.84 - 1.88 |
Market Cap | $398.82M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 8.61% |
Days to Cover | 9.22 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Precigen (NASDAQ:PGEN) through any online brokerage.
Other companies in Precigen’s space includes: Cabaletta Bio (NASDAQ:CABA), Voyager Therapeutics (NASDAQ:VYGR), Altimmune (NASDAQ:ALT), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
There is no analysis for Precigen.
Precigen has a consensus price target of $6.00.
The stock price for Precigen (NASDAQ: PGEN) is $1.58 last updated June 28, 2024 at 4:19 PM EDT.
There are no upcoming dividends for Precigen.
Precigen’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Precigen.
Precigen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.